Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03849625

Enrollment

158

Registered

2019-02-21

Start date

2015-05-01

Completion date

2020-03-31

Last updated

2022-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspirin Allergy, Aspirin-exacerbated Respiratory Disease, Aspirin-Induced Anaphylactoid Reaction, Aspirin-Induced Angioedema-Urticaria, Aspirin Sensitivity, NSAID-Induced Anaphylactoid Reaction, NSAID-Induced Angioedema-Urticaria, NSAID-Induced Asthma

Brief summary

Study clinical characteristics and phenotypes of patients diagnosed with NSAID sensitivity in Thailand

Interventions

DRUGaspirin, NSAIDs, paracetamol

Perform skin test and/or provocation test with aspirin, paracetmol, or suspected NSAIDs in questionable cases

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to No maximum

Healthy volunteers

Inclusion criteria

* Thai patients with a history of an immediate reaction to aspirin/paracetamol, or NSAIDs visiting King Chulalongkorn memorial Hospital

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Results of skin test/provocation test	4 years	Positive, negative, or equivocal

Secondary

Measure	Time frame
Phenotypes of allergic reactions	4 years
Urine leukotriene E4	4 years

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026